BioNetwork West 2015 (past event)

October 26 - 28, 2015

Contact Us: 1.888.482.6012

Joshua Grass, Senior Vice President of Corporate and Business Development at BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc Logo

Joshua Grass


Senior Vice President of Corporate and Business Development
BioMarin Pharmaceutical Inc

Check out the incredible speaker line-up to see who will be joining Joshua.

Download The Latest Agenda

Innovative Dealmaking

Friday, February 10th, 2017


09:00 Therapeutic Focus Area Ice Breaker Roundtables

Get to know others with similar interests as you. Choose the therapeutic area at the top of your partnership priorities. You'll sit with 10 - 20 others seeking similar opportunities to debate the advantages and challenges assocatied with your chosen area, and start making connections!

#1 Neurodegenerative Diseases
Ilan Zipkin, Senior Investment Director, Takeda Ventures

#2 Rare Disease
Joshua A. Grass, SVP, Business and Corporate Development, BioMarin Pharmaceutical

#3 Biosimilars Across Therapeutic Areas
Michael Bayewitch, Director, Search & Evaluation, Biologics, Teva Pharmaceuticals

#4 Immunology
Kia Motesharei, Head, Global Licensing & Business Development, Immunology, EMD Serono

#5 Gene Therapy
John McDonald, VP Business Development and Mergers & Acquisitions, Biogen

#6 Oncology
Michael Attar, Executive Director, Business Development, Celgene Corporation

#7 Other (Free Flow Table)